Legend Biotech holder plans $50.9K ADS sale

Shareholder Carlos E. Santos files a Rule 144 notice to sell 2,715 Legend Biotech ADSs, partly to cover tax obligations from vested equity awards.

Rhea-AI Filing Summary

Legend Biotech Corp (LEGN) is the issuer of American Depositary Shares that a shareholder, Carlos E. Santos, has filed to sell under Rule 144. The notice covers a proposed sale of 2,715 American Depositary Shares through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $50,854.12 as of September 22, 2026.

The shares were acquired from the issuer on September 18, 2026 via restricted stock vesting as compensation. The filing states that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of the vested equity award distribution.

Key Figures

Shares to be sold: 2,715 American Depositary Shares Aggregate market value: $50,854.12 Proposed sale date reference: September 22, 2026 +1 more

4 metrics

Shares to be sold 2,715 American Depositary Shares Amount of Legend Biotech ADSs covered by the Rule 144 notice

Aggregate market value $50,854.12 Market value of the 2,715 ADSs as of September 22, 2026

Proposed sale date reference September 22, 2026 Date tied to market value and NASDAQ sale information

Acquisition date September 18, 2026 Date the 2,715 ADSs were acquired via restricted stock vesting

Key Terms

Rule 144, American Depositary Shares, Restricted Stock Vesting, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

American Depositary Shares financial

"American Depositary Shares | Fidelity Brokerage Services LLC"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Restricted Stock Vesting financial

"American Depositary Shares | 09/18/2026 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Carlos E. Santos Garcia"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Legend Biotech Corp (LEGN)?

It discloses that Carlos E. Santos plans to sell 2,715 American Depositary Shares of Legend Biotech Corp under Rule 144, through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $50,854.12 as of September 22, 2026.

How many Legend Biotech (LEGN) shares are covered by this Form 144?

The Form 144 covers a proposed sale of 2,715 American Depositary Shares of Legend Biotech Corp. These shares were acquired via restricted stock vesting on September 18, 2026 as part of a compensation arrangement with the issuer.

What is the approximate value of the Legend Biotech (LEGN) shares to be sold?

The notice lists an aggregate market value of $50,854.12 for the 2,715 American Depositary Shares of Legend Biotech Corp to be sold under Rule 144, based on market data as of September 22, 2026.

When were the Legend Biotech (LEGN) shares acquired and how?

The 2,715 American Depositary Shares were acquired on September 18, 2026 from Legend Biotech Corp through Restricted Stock Vesting. The filing identifies the nature of acquisition as Compensation from the issuer.

Why is a portion of the Legend Biotech (LEGN) shares being sold?

The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution tied to the restricted stock vesting.

Who is executing the sale of Legend Biotech (LEGN) shares under this Form 144?

The sale is to be executed through Fidelity Brokerage Services LLC. The Form 144 is signed by Jennifer Ruchti, as a duly authorized representative of Fidelity, acting as attorney-in-fact for Carlos E. Santos Garcia.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 03:31 PM Accepted by SEC EDGAR 09/22/2026 - 03:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002097065
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Legend Biotech Corp
SEC File Number	001-39307
Address of Issuer	2101 COTTONTAIL LANE SOMERSET NEW JERSEY 08873
Phone	732-850-5598
Name of Person for Whose Account the Securities are To Be Sold	Santos Carlos E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2715	50854.12	369886369	09/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	09/18/2026	Restricted Stock Vesting	Issuer			2715	09/18/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Carlos E. Santos Garcia
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)